Adeno-associated virus 2-mediated transduction and erythroid lineage- restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells

Journal of Hematotherapy and Stem Cell Research

Volumn 8, Issue 6, 1999, Pages 585-592

  Kurpad, Chandrika ^a,b,c   Mukherjee, Pinku ^a,b,c   Wang, X U Shan ^a,b,c   Ponnazhagan, Selvarangan ^a,b,c   Li, Linglin ^b   Yoder, Mervin C ^a,b   Srivastava, Arun ^a,b,c  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WALTHER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BETA GLOBIN; CD34 ANTIGEN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; BETA THALASSEMIA; CELL DIFFERENTIATION; CONTROLLED STUDY; ERYTHROID CELL; GENE THERAPY; GLOBIN GENE; HEMATOPOIETIC STEM CELL; HEMOGLOBINOPATHY; HUMAN; HUMAN CELL; PARVOVIRUS; PRIORITY JOURNAL; SICKLE CELL ANEMIA; VIRUS GENE; VIRUS RECOMBINANT;

ANEMIA, SICKLE CELL; ANTIGENS, CD34; BETA-GALACTOSIDASE; BETA-THALASSEMIA; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; CYTOMEGALOVIRUS; DEPENDOVIRUS; ENHANCER ELEMENTS (GENETICS); ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE THERAPY; GENES, REPORTER; GENES, VIRAL; GENETIC VECTORS; GLOBINS; HEMATOPOIETIC STEM CELLS; HUMANS; LAC OPERON; ORGAN SPECIFICITY; PARVOVIRUS B19, HUMAN; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 0033451091     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581699319740     Document Type: Article

References (51)

1. Berns KI. (1990). Parvovirus replication. Microbiol Rev 54:316.
2. Berns KI, and RM Linden. (1995). The cryptic life style of adeno-associated virus. Bioessays 17:237.
3. Brown KE, NS Young and JM Liu. (1994). Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol 16:1.
4. Cotmore SF, and P Tattersall. (1984). Characterization and molecular cloning of a human parvovirus genome. Science 226:1161.
5. Kotin RM, and KI Berns. (1989). Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology 170:460.
6. Kotin RM, JC Menninger, DC Ward and KI Berns. (1991). Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10:831.
7. Kotin RM, M Siniscalco, RJ Samulski, X Zhu, L Hunter, CA Laughlin, S McLaughlin, N Muzyczka, M Rocchi and KI Berns. (1990). Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 87:2211.
8. RJ Samulski, X Zhu, X Xiao, JD Brook, DE Housman, N Epstein and LA Hunter. (1991). Targeted integration of adeno-associated virus into chromosome 19. EMBO J 10:3941.
9. Podsakoff G, KK Wong Jr and S Chatterjee. (1994). Efficient gene transfer into non-dividing cells by adeno-associated virus based vectors. J Virol 68:5656.
10. Summerford C, and RJ Samulski. (1988). Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72:1438.
11. Quing KY, C Mah, J Hansen, SZ Zhou, V Dwarki and A Strivastava. (1999). Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nature Med 5:71.
12. Summerford C, JS Bartlett and RJ Samulski. (1999). αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nature Med 5:78.
13. Muzyczka N. (1992). Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol 158:97.
14. Carter BJ. (1992). Adeno-associated virus vectors. Curr Opin Biotechnol 3:533.
15. Srivastava A. (1994). Parvovirus-based vectors for human gene therapy. Blood Cells 20:531.
16. Berns KI and C Giraud. (1996). Biology of adeno-associated virus. Curr Top Microbiol Immunol 218:1.
17. Chatterjee S, D Lu, G Podsakoff and KK Wong Jr. (1995). Strategies for efficient gene transfer into hematopoietic cells: the use of adeno-associated virus vectors in gene therapy. Ann NY Acad Sci 770:79.
18. Donahue RE, SW Kessler, DM Bodine, K McDonagh, C Dunbar, S Goodman, B Agricola, E Byrne, M Raffeld, R Moen, J Bacher, KM Zsebo and AW Nienhuis. (1992). Helper virus induced T cell lymphoma in non-human primates after retroviral mediated gene transfer. J Exp Med 176:1125.
19. Knowles MR, KW Hohneker, Z Zhou, JC Olsen, TL Noah, P-C Hu, MW Leigh, JF Engelhardt, K Edwards, KR Jones, M Grossman, JM Wilson, LG Johnson and RC Boucher. (1995). A controlled study of adenoviral vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 333:823.
20. Cossart YE, AM Field, B Cant and D Widdows. (1975). Parvovirus-like particles in human sera. Lancet 2:72.
21. Ozawa K, G Kurtzman and NS Young. (1986). Replication of the B19 parvovirus in human bone marrow cell cultures. Science 233:883.
22. Ozawa K, G Kurtzman and NS Young. (1987). Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood 70:384.
23. Srivastava A, and L Lu. (1988). Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J Virol 62:3059.
24. Srivastava CH, RJ Samulski, L Lu, SH Larsen and A Srivastava. (1989). Construction of a recombinant human parvovirus B19: adeno-associated virus-2 (AAV) DNA inverted terminal-repeats are functional in an AAV-B19 hybrid virus. Proc Natl Acad Sci USA 86:8078.
25. Yaegashi N, M Shiraishi, T Takeshita, M Nakamura, A Yajima and K Sugamura. (1989). Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J Virol 63:2422.
26. Srivastava A, E Bruno, R Briddell, R Cooper, C Srivastava, K van Besien and R Hoffman. (1990). Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 76:1997.
27. Takahashi T, K Ozawa, S Takahashi, S Asano and F Takaku. (1990). Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood 75:603.
28. Srivastava CH, SZ Zhou, NC Munshi and A Srivastava. (1992). Parvovirus B19 replication in human umbilical cord blood cells. Virology 189:456.
29. Schwarz TF, S Serke, B Hottentrager, A von Brunn, H Bauermann, A Kirsch, W Stolz, D Huhn, F Deinhardt and M Roggendorf. (1992). Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood. J Virol 66:1273.
30. Mortimer PP, RK Humphries, JG Moore, RH Purcell and NS Young. (1983). A human parvovirus-like virus inhibits hematopoietic colony formation in vitro. Nature 302:426.
31. Brown KE, SM Anderson and NS Young. (1993). Erythrocyte P antigen - cellular receptor for B19 parvovirus. Science 262:114.
32. von dem Borne AEGK, MJE Bos, N Joustra-Maas, JF Tromp, R van Wijngaarden-du Bois and PAT Tetteroo. (1986). A murine monoclonal IgM antibody specific for blood group P antigen (globoside). Br J Haematol 63:35.
33. Ponnazhagan S, MJ Woody, X-S Wang, SZ Zhou and A Srivastava. (1995). Transcriptional transactivation of parvovirus B19 promoters in non-permissive human cells by adenovirus type 2. J Virol 69:8096.
34. Ponnazhagan S, X-S Wang, MJ Woody, F Luo, LY Kang, ML Nallari, NC Munshi, SZ Zhou and A Srivastava. (1996). Differential expression from parvovirus B19p6 promoter in human cells following plasmid transfection and recombinant adeno-associated virus-2 mediated infection: human megakaryocytic leukemia cells are nonpermissive for AAV infection. J Gen Virol 77:1111.
35. Wang X-S, MC Yoder, SZ Zhou and A Srivastava. (1995). Parvovirus B19 promoter at map unit 6 confers replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells. Proc Natl Acad Sci USA 92:12416.
36. + hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation. J Virol 71:8262.
37. Ponnazhagan S, MC Yoder and A Srivastava. (1997). Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo. J Virol 71:3098.
38. Tuan DYH, WB Solomon, IM London and DP Lane. (1989). An erythroid specific development stage independent enhancer far upstream of the human "β-like globin" genes. Proc Natl Acad Sci USA 86:2554.
39. Nahreini P, MJ Woody, SZ Zhou and A Srivastava. (1993). Versatile adeno-associated virus-2 based vectors for constructing recombinant virions. Gene 124:257.
40. Ponnazhagan S, P Mukherjee, MC Yoder, X-S Wang, SZ Zhou, J. Kaplan, S Wadsworth and A Srivastava. (1997). Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene 190:203.
41. Kube DM, and A Srivastava. (1997). Quantitative DNA slot blot analysis: inhibition of DNA binding to membranes by magnesium ions. Nucleic Acids Res 25:3375.
42. Wang X-S, B Khuntirat, KY Qing, S Ponnazhagan, DM Kube, SZ Zhou, VJ Kwarki and A Srivastava. (1998). Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination. J Virol 72:5472.
43. Clapp DW, B Freie, EF Srour, MC Yoder, K Fortney and SL Gerson. (1995). Myeloproliferative sarcoma virus directed expression of β-galactosidase following retroviral transduction of murine hematopoietic cells. Exp Hematol 23:630.
44. Yoder MC, B King, K Hiatt, P Mukherjee and DA Williams. (1995). Growth of bone marrow high proliferative potential colony forming cells during in vitro co-culture with murine embryonic yolk sac cell lines. Blood 86:1322.
45. Zhou SZ, Q Li, S Stamatoyannopoulos and A Srivastava. (1996). Adeno-associated virus 2-mediated transduction and erythroid cell-specific expression of a human β-globin gene. Gene Ther 3:223.
46. Fraser P, J Hurst, P Collis and F Grosveld. (1990). DNase I hypersensitive sites 1, 2 and 3 of the human β-globin dominant control region direct position-independent expression. Nucleic Acids Res 18:3503.
47. Walsh CE, JM Liu, X Xiao, NS Young, AW Nienhuis and RJ Samulski. (1992). Regulated high level expression of a human γ-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sci USA 89:7257.
48. Miller JL, RE Donahue, SE Sellers, RJ Samulski, NS Young and AW Nienhuis. (1992). Recombinant adeno-associated virus (rAAV)-mediated expression of human γ-globin gene in human progenitor-derived erythroid cells. Proc Natl Acad Sci USA 91:10183.
49. Walsh CE, JM Liu, JM Miller, AW Nienhuis and RJ Samulski. (1993). Gene therapy for human hemoglobinopathies. Proc Soc Exp Biol Med 204:289.
50. Einerhand MPW, M Antoniou, S Zolotukhin, N Muzyczka, KI Berns, F Grosveld and D Valerio. (1995). Regulated high-level human beta-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer. Gene Ther 2:336.
51. Zhou SZ, S Cooper, LY Kang, L Ruggieri, S Heimfeld, A Srivastava and HE Broxmeyer. (1994). Adeno-associated virus 2-mediated high-efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med 179:1867.